Articular Diffusion of Meloxicam After a Single Oral Dose: Relationship to Cyclo-Oxygenase Inhibition in Synovial Cells

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.39, Iss.5, 2000-11, pp. : 369-382

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of cyclo-oxygenase and lipoxygenase reviewed

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 and its Inhibition in Cancer: Is There a Role?

By Liao Zhongxing

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 821-845

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Meloxicam: A Cyclo-Oxygenase-2 Preferential Nonsteroidal Anti-Inflammatory Drug

By Davies N.M.

Clinical Pharmacokinetics, Vol. 36, Iss. 2, 1999-02 ,pp. : 115-126

Adis International

Access to resources Recommend Favorite

Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes

By Tsubouchi Y. Sano H. Yamada R. Hashiramoto A. Kohno M. Kusaka Y. Kondo M.

European Journal of Pharmacology, Vol. 395, Iss. 3, 2000-05 ,pp. : 255-263

Elsevier

Access to resources Recommend Favorite

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

By Rioja I. Terencio M.C. Ubeda A. Molina P. Tarraga A. Gonzalez-Tejero A. Alcaraz M.J.

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite